Novel & Emerging Psychoactives
Xylazine, medetomidine, kratom, tianeptine, nitazenes, designer benzodiazepines, research chemicals.
Latest reporting
Massachusetts Bans All Kratom, Going Further Than the Feds Just Did
Massachusetts Gov. Maura Healey placed all kratom products into Schedule I, a broader ban than the federal government's own July move targeting only concentrated 7-OH extracts.
Treatment Centers Are Seeing a Kratom Wave the DEA's New Rule Won't Touch
Kratom-dependence admissions are surging at U.S. treatment centers even as the DEA moves to schedule only its most concentrated extract. The people showing up for care were never buying the extract — they were buying a supplement aisle promise.
Naloxone Still Saves Lives. It Can't Touch the Drug That's Replacing Xylazine.
Medetomidine, a veterinary sedative, is now twice as common as xylazine in Philadelphia's drug supply. Naloxone doesn't reverse it, and there's no approved antidote.
Through eight lenses
Science
Alpha-2 agonists (xylazine, medetomidine — veterinary sedatives), nitazenes as μ-opioid agonists (synthesized in 1950s, never approved, re-emerging), kratom mitragynine partial μ-agonist + alpha-2, tianeptine atypical antidepressant with opioid activity at high doses.
Biology
Xylazine causes necrotic skin ulcers characteristic + prolonged sedation not reversed by naloxone; nitazenes act like high-potency fentanyl analogs (naloxone-reversible, higher dosing may be needed); kratom has its own withdrawal syndrome; tianeptine "gas station heroin" causing emergency-dept surges.
Psychology
Dependence patterns mirror the parent class but often with gaps in clinical recognition.
Policy
DEA scheduling scramble — xylazine FDA-declared emerging threat, nitazene analogs being scheduled piecemeal, kratom DEA deferred twice, tianeptine state-by-state patchwork.
Trends
Xylazine now in 48 states' supply; medetomidine identified in Chicago-area 2024; kratom retail boom.
The Drug That's Replacing Xylazine Is Already Winning, and Your Test Strip Can't See It
Jul 28The DEA Started a 30-Day Clock on Banning Concentrated Kratom Extracts. Whole-Leaf Kratom Isn't What's on Trial.
Jul 24Naloxone Doesn't Touch It: A Veterinary Sedative Is Quietly Taking Over Where Xylazine Left Off
Jul 7
Treatment
Xylazine wound care + opioid co-treatment; nitazene overdose reversal with naloxone; kratom dependence — buprenorphine effective; tianeptine dependence — like opioids.
Harm Reduction
Test strips for xylazine + nitazenes (where available), stay with person during prolonged sedation, don't use alone, high-dose naloxone availability.